Society For Research On Nicotine & Tabacco Inc.

Society For Research On Nicotine & Tabacco Inc., a tax-exempt nonprofit scientific society based in Windsor, Wisconsin, operates as a prime recipient of federal grants and contracts that fund its annual conferences and tobacco regulatory science research advancement, with all recent awards directed to the Food and Drug Administration (FDA) and the National Institutes of Health (NIH).

SRNT is the only international scientific society dedicated exclusively to nicotine and tobacco research, with over 1,200 members from more than 40 countries, approximately 85 percent of whom are affiliated with U.S. academic, research, government, and advocacy organizations. The organization's federal footprint centers on conference support and research convening rather than consulting or professional services delivery. Across the past five years, SRNT has received 19 awards with a combined potential value of $305 thousand, though obligated dollars total $1.3 million (429 percent of potential value), reflecting multi-year grant performance and prior funding reallocations. Customer concentration is acute: the FDA and the NIH account for 89 percent of awards by count, split between the FDA's Center for Tobacco Products (8 awards) and NIH funders including the National Cancer Institute (3 awards, $106 thousand combined potential value) and the Office of the Director (3 awards, $45 thousand combined potential value).

Recent representative work includes a $105,925 definitive firm fixed-price contract awarded by the FDA on March 4, 2026, for conference registration and support services for the 2026 SRNT Annual Meeting in Baltimore, Maryland, covering registration processing for FDA Center for Tobacco Products staff and on-site conference support through April 7, 2026. Concurrently, the FDA awarded a project grant on March 1, 2026 (ultimate completion February 28, 2027) to support the 2026 Annual Meeting with content aligned to the FDA's Tobacco Regulatory Science Program priorities, including curation of paper sessions, special oral sessions for trainees and early-career investigators, professional development forums, and travel awards. The organization has received similar annual conference grants from the NIH National Cancer Institute (2024 award for global support elevating low- and middle-income country researcher participation) and from the Center for Tobacco Products (grants awarded in 2022, 2023, 2024, and 2025) to support annual meeting program development tied to regulatory science research priorities.

SRNT operates exclusively as a prime award recipient with zero subcontract exposure. The organization maintains no parent contract vehicles and competes in full-and-open procurements without set-aside designation. One award reaches ultimate completion in the next twenty-four months, representing minimal recompete exposure in that window.